首页|酚妥拉明联合多巴胺对重症肺炎患儿的疗效及安全性研究

酚妥拉明联合多巴胺对重症肺炎患儿的疗效及安全性研究

扫码查看
目的 研究酚妥拉明联合多巴胺对重症肺炎患儿疗效及安全性的影响.方法 选取2014年5月~2016年7月银川市第三人民医院收治的重症肺炎患儿94例,根据随机数字表法分为观察组47例,对照组47例.其中对照组行常规治疗,观察组则在对照组的基础上加用酚妥拉明联合多巴胺治疗.分别对比2组疗效,各项临床症状消失时间,治疗前后APACHEⅡ评分以及不良反应发生情况.结果 观察组治疗总有效率为93.62%(44/47),高于对照组的76.60%(36/47),差异具有统计学意义(P<0.05).观察组患儿各项临床症状消失时间中,咳嗽消失时间为(5.1±1.5)d,发热消失时间为(3.1±1.2)d,啰音消失时间为(5.4±1.3)d,气促消失时间为(2.3±1.1)d,均分别低于对照组的(9.4±3.1)d、(6.6±1.7)d、(9.2±1.6)d、(4.9±1.4)d,差异具有统计学意义(P<0.05).治疗后2组APACHEⅡ评分均显著下降,而观察组又显著低于对照组,差异具有统计学意义(P<0.05).观察组不良反应发生率为8.51%(4/47),低于对照组的27.66%(13/47),差异具有统计学意义(P<0.05).结论 酚妥拉明联合多巴胺治疗重症肺炎患儿的疗效显著,有利于改善患儿临床症状,减轻细胞炎症反应,具有较好的安全性.
Effect and safety of Phentolamine combined with Dopamine on treatment of severe pneumonia in children
Objective To study the effect of Phentolamine combined with Dopamine on the efficacy and safety of children with severe pneumonia. Methods 94 cases of severe pneumonia treated by the third People's hospital of Yinchuan city from May 2014 to July 2016 were selected as study objects, and 47 cases were divided into the observation group according to the random number table method, and 47 cases in the control group. The control group was treated with routine treatment, and the observation group was treated with Phentolamine combined with Dopaminergic therapy on the basis treatment of the control group. Curative effect, the clinical symptoms disappear time, the APACHE Ⅱ ratings before and after treatment and adverse reactions of two groups were compared. Results The total effective rate of the observation group was 93.62%(44/47), compared with 76.60% (36/47) in the control group, with significant difference (P<0.05). Various clinical symptoms disappear time, cough disappeared time in the observation group was (5.1±1.5) d, fever disappeared time was (3.1±1.2) d, then the sound disappear time wass (5.4±1.3) d, shortness of breath disappear time was (2.3±1.1) d, these were respectively lower than in the control group (9.4±3.1) d, (6.6±1.7) d, (9.2±1.6) d, (4.9±1.4) d, with significant difference (P<0.05). APACHE Ⅱ scores in the two groups after treatment were significantly decreased, while the observation group was significantly lower than the control group, the differences were statistically significant (P<0.05). The adverse reaction rate of the observation group was 8.51% (4/47), compared with 27.66% (13/47) of the control group, with significant difference (P<0.05). Conclusion The effect of Phentolamine combined with Dopamine in treating children with severe pneumonia is significant, which is beneficial to improve the clinical symptoms of children and can reduce the inflammatory response of the cells, and has good safety.

severe pneumoniaPhentolamineDopamine

季立洪、李惠蓉

展开 >

银川市第三人民医院 儿科,宁夏 银川 750004

重症肺炎 酚妥拉明 多巴胺

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(11)
  • 16